The metabolic syndrome

Robert H. Eckel, Scott M. Grundy, Paul Zimmet

Research output: Contribution to journalArticle

3933 Citations (Scopus)

Abstract

The metabolic syndrome is a common metabolic disorder that results from the increasing prevalence of obesity. The disorder is defined in various ways, but in the near future a new definition(s) will be applicable worldwide. The pathophysiology seems to be largely attributable to insulin resistance with excessive flux of fatty acids implicated. A proinflammatory state probably contributes to the syndrome. The increased risk for type 2 diabetes and cardiovascular disease demands therapeutic attention for those at high risk. The fundamental approach is weight reduction and increased physical activity; however, drug treatment could be appropriate for diabetes and cardiovascular disease risk reduction.

LanguageEnglish
Pages1415-1428
Number of pages14
JournalLancet
Volume365
Issue number9468
DOIs
Publication statusPublished - 16 Apr 2005

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Eckel, R. H., Grundy, S. M., & Zimmet, P. (2005). The metabolic syndrome. Lancet, 365(9468), 1415-1428. https://doi.org/10.1016/S0140-6736(05)66378-7
Eckel, Robert H. ; Grundy, Scott M. ; Zimmet, Paul. / The metabolic syndrome. In: Lancet. 2005 ; Vol. 365, No. 9468. pp. 1415-1428.
@article{33b1126a19f94515a7f415f00af0dbc8,
title = "The metabolic syndrome",
abstract = "The metabolic syndrome is a common metabolic disorder that results from the increasing prevalence of obesity. The disorder is defined in various ways, but in the near future a new definition(s) will be applicable worldwide. The pathophysiology seems to be largely attributable to insulin resistance with excessive flux of fatty acids implicated. A proinflammatory state probably contributes to the syndrome. The increased risk for type 2 diabetes and cardiovascular disease demands therapeutic attention for those at high risk. The fundamental approach is weight reduction and increased physical activity; however, drug treatment could be appropriate for diabetes and cardiovascular disease risk reduction.",
author = "Eckel, {Robert H.} and Grundy, {Scott M.} and Paul Zimmet",
year = "2005",
month = "4",
day = "16",
doi = "10.1016/S0140-6736(05)66378-7",
language = "English",
volume = "365",
pages = "1415--1428",
journal = "Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "9468",

}

Eckel, RH, Grundy, SM & Zimmet, P 2005, 'The metabolic syndrome', Lancet, vol. 365, no. 9468, pp. 1415-1428. https://doi.org/10.1016/S0140-6736(05)66378-7

The metabolic syndrome. / Eckel, Robert H.; Grundy, Scott M.; Zimmet, Paul.

In: Lancet, Vol. 365, No. 9468, 16.04.2005, p. 1415-1428.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The metabolic syndrome

AU - Eckel, Robert H.

AU - Grundy, Scott M.

AU - Zimmet, Paul

PY - 2005/4/16

Y1 - 2005/4/16

N2 - The metabolic syndrome is a common metabolic disorder that results from the increasing prevalence of obesity. The disorder is defined in various ways, but in the near future a new definition(s) will be applicable worldwide. The pathophysiology seems to be largely attributable to insulin resistance with excessive flux of fatty acids implicated. A proinflammatory state probably contributes to the syndrome. The increased risk for type 2 diabetes and cardiovascular disease demands therapeutic attention for those at high risk. The fundamental approach is weight reduction and increased physical activity; however, drug treatment could be appropriate for diabetes and cardiovascular disease risk reduction.

AB - The metabolic syndrome is a common metabolic disorder that results from the increasing prevalence of obesity. The disorder is defined in various ways, but in the near future a new definition(s) will be applicable worldwide. The pathophysiology seems to be largely attributable to insulin resistance with excessive flux of fatty acids implicated. A proinflammatory state probably contributes to the syndrome. The increased risk for type 2 diabetes and cardiovascular disease demands therapeutic attention for those at high risk. The fundamental approach is weight reduction and increased physical activity; however, drug treatment could be appropriate for diabetes and cardiovascular disease risk reduction.

UR - http://www.scopus.com/inward/record.url?scp=17144380822&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(05)66378-7

DO - 10.1016/S0140-6736(05)66378-7

M3 - Article

VL - 365

SP - 1415

EP - 1428

JO - Lancet

T2 - Lancet

JF - Lancet

SN - 0140-6736

IS - 9468

ER -

Eckel RH, Grundy SM, Zimmet P. The metabolic syndrome. Lancet. 2005 Apr 16;365(9468):1415-1428. https://doi.org/10.1016/S0140-6736(05)66378-7